Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 132

1.

A Novel Approach to Infectious Disease Preparedness: Incorporating Investigational Therapeutics and Research Objectives into Full-Scale Exercises.

Vasa A, Madad S, Larson L, Kraft CS, Vanairsdale S, Grein JD, Garland J, Butterworth VM, Kratochvil CJ.

Health Secur. 2019 Jan/Feb;17(1):54-61. doi: 10.1089/hs.2018.0100.

PMID:
30779611
2.

The Special Pathogens Research Network: Enabling Research Readiness.

Kraft CS, Kortepeter MG, Gordon B, Sauer LM, Shenoy ES, Eiras DP, Larson L, Garland JA, Mehta AK, Barrett K, Price CS, Croyle C, West LR, Noren B, Kline S, Arguinchona C, Arguinchona H, Grein JD, Connally C, McLellan S, Risi GF, Uyeki TM, Davey RT Jr, Schweinle JE, Schwedhelm MM, Harvey M, Hunt RC, Kratochvil CJ.

Health Secur. 2019 Jan/Feb;17(1):35-45. doi: 10.1089/hs.2018.0106.

PMID:
30779607
3.

Evaluating Promising Investigational Medical Countermeasures: Recommendations in the Absence of Guidelines.

Bhadelia N, Sauer L, Cieslak TJ, Davey RT, McLellan S, Uyeki TM, Kortepeter MG; National Ebola Training and Education Center's Special Pathogens Research Network (SPRN)'s Medical Countermeasures Working Group.

Health Secur. 2019 Jan/Feb;17(1):46-53. doi: 10.1089/hs.2018.0092. Epub 2019 Feb 6.

PMID:
30724616
4.

Macrophage Activation Marker Soluble CD163 Associated with Fatal and Severe Ebola Virus Disease in Humans1.

McElroy AK, Shrivastava-Ranjan P, Harmon JR, Martines RB, Silva-Flannery L, Flietstra TD, Kraft CS, Mehta AK, Lyon GM, Varkey JB, Ribner BS, Nichol ST, Zaki SR, Spiropoulou CF.

Emerg Infect Dis. 2019 Feb;25(2):290-298. doi: 10.3201/eid2502.181326.

5.

Tuberculosis following PD-1 blockade for cancer immunotherapy.

Barber DL, Sakai S, Kudchadkar RR, Fling SP, Day TA, Vergara JA, Ashkin D, Cheng JH, Lundgren LM, Raabe VN, Kraft CS, Nieva JJ, Cheever MA, Nghiem PT, Sharon E.

Sci Transl Med. 2019 Jan 16;11(475). pii: eaat2702. doi: 10.1126/scitranslmed.aat2702.

PMID:
30651320
6.

The Use of Microbiome Restoration Therapeutics to Eliminate Intestinal Colonization With Multidrug-Resistant Organisms.

Gopalsamy SN, Woodworth MH, Wang T, Carpentieri CT, Mehta N, Friedman-Moraco RJ, Mehta AK, Larsen CP, Kraft CS.

Am J Med Sci. 2018 Nov;356(5):433-440. doi: 10.1016/j.amjms.2018.08.015. Epub 2018 Aug 29.

PMID:
30384952
7.

Designing Studies Acceptable for Abstraction and Inclusion in Evidence-Based Laboratory Practice Guidelines.

Saubolle MA, Weissfeld AS, Kraft CS.

J Clin Microbiol. 2018 Oct 10. pii: JCM.00842-18. doi: 10.1128/JCM.00842-18. [Epub ahead of print]

8.

Making the invisible visible: Why does design matter for safe doffing of personal protection equipment?

Zimring CM, Matić Z, Wong Sala MF, Mumma JM, Kraft CS, Casanova LM, Erukunuakpor K, Durso FT, Walsh VL, Shah P, Jacob JT, DuBose JR; CDC Prevention Epicenters Program.

Infect Control Hosp Epidemiol. 2018 Nov;39(11):1375-1377. doi: 10.1017/ice.2018.206. Epub 2018 Oct 2. No abstract available.

PMID:
30277187
9.

Determining qualitative effect size ratings using a likelihood ratio scatter matrix in diagnostic test accuracy systematic reviews.

Rubinstein ML, Kraft CS, Parrott JS.

Diagnosis (Berl). 2018 Nov 27;5(4):205-214. doi: 10.1515/dx-2018-0061.

PMID:
30243015
10.

Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience.

Cheng YW, Phelps E, Ganapini V, Khan N, Ouyang F, Xu H, Khanna S, Tariq R, Friedman-Moraco RJ, Woodworth MH, Dhere T, Kraft CS, Kao D, Smith J, Le L, El-Nachef N, Kaur N, Kowsika S, Ehrlich A, Smith M, Safdar N, Misch EA, Allegretti JR, Flynn A, Kassam Z, Sharfuddin A, Vuppalanchi R, Fischer M.

Am J Transplant. 2019 Feb;19(2):501-511. doi: 10.1111/ajt.15058. Epub 2018 Aug 31.

PMID:
30085388
11.

Developing and Assessing the Feasibility of a Home-based Preexposure Prophylaxis Monitoring and Support Program.

Siegler AJ, Mayer KH, Liu AY, Patel RR, Ahlschlager LM, Kraft CS, Fish R, Wiatrek SE, Sullivan PS.

Clin Infect Dis. 2019 Jan 18;68(3):501-504. doi: 10.1093/cid/ciy529.

12.

Relationship-focused vs. Structural Activities in Medical Home Measurement in Pediatrics.

Stille CJ, Raphael JL, Carle AC, Keller DM, Turchi RM, Kraft CA, Mann MY, Bright D.

Matern Child Health J. 2018 Nov;22(11):1580-1588. doi: 10.1007/s10995-018-2552-8.

PMID:
29926246
13.

Design strategies to improve healthcare worker safety in biocontainment units: learning from ebola preparedness.

DuBose JR, Matić Z, Sala MFW, Mumma JM, Kraft CS, Casanova LM, Erukunuakpor K, Durso FT, Walsh VL, Shah P, Zimring CM, Jacob JT; CDC Prevention Epicenters Program.

Infect Control Hosp Epidemiol. 2018 Aug;39(8):961-967. doi: 10.1017/ice.2018.125. Epub 2018 Jun 18.

PMID:
29909821
14.

Evaluation of Performance Characteristics of Panther Fusion Assays for Detection of Respiratory Viruses from Nasopharyngeal and Lower Respiratory Tract Specimens.

Sam SS, Caliendo AM, Ingersoll J, Abdul-Ali D, Hill CE, Kraft CS.

J Clin Microbiol. 2018 Jul 26;56(8). pii: e00787-18. doi: 10.1128/JCM.00787-18. Print 2018 Aug.

15.

Novel PET and Near Infrared Imaging Probes for the Specific Detection of Bacterial Infections Associated With Cardiac Devices.

Takemiya K, Ning X, Seo W, Wang X, Mohammad R, Joseph G, Titterington JS, Kraft CS, Nye JA, Murthy N, Goodman MM, Taylor WR.

JACC Cardiovasc Imaging. 2018 Apr 13. pii: S1936-878X(18)30207-9. doi: 10.1016/j.jcmg.2018.02.011. [Epub ahead of print]

PMID:
29680350
16.

Ebola Virus Persistence in Ocular Tissues and Fluids (EVICT) Study: Reverse Transcription-Polymerase Chain Reaction and Cataract Surgery Outcomes of Ebola Survivors in Sierra Leone.

Shantha JG, Mattia JG, Goba A, Barnes KG, Ebrahim FK, Kraft CS, Hayek BR, Hartnett JN, Shaffer JG, Schieffelin JS, Sandi JD, Momoh M, Jalloh S, Grant DS, Dierberg K, Chang J, Mishra S, Chan AK, Fowler R, O'Dempsey T, Kaluma E, Hendricks T, Reiners R, Reiners M, Gess LA, ONeill K, Kamara S, Wurie A, Mansaray M, Acharya NR, Liu WJ, Bavari S, Palacios G, Teshome M, Crozier I, Farmer PE, Uyeki TM, Bausch DG, Garry RF, Vandy MJ, Yeh S.

EBioMedicine. 2018 Apr;30:217-224. doi: 10.1016/j.ebiom.2018.03.020. Epub 2018 Mar 23.

17.

Severe Community-Acquired Pneumonia due to Acinetobacter baumannii in North America: Case Report and Review of the Literature.

Serota DP, Sexton ME, Kraft CS, Palacio F.

Open Forum Infect Dis. 2018 Mar 10;5(3):ofy044. doi: 10.1093/ofid/ofy044. eCollection 2018 Mar.

18.

Long-term stability of CMV DNA in human breast milk.

Sam SS, Ingersoll J, Racsa LD, Caliendo AM, Racsa PN, Igwe D, Abdul-Ali D, Josephson C, Kraft CS.

J Clin Virol. 2018 May;102:39-41. doi: 10.1016/j.jcv.2018.02.014. Epub 2018 Feb 21.

PMID:
29486386
19.

Assessing Viral Transfer During Doffing of Ebola-Level Personal Protective Equipment in a Biocontainment Unit.

Casanova LM, Erukunuakpor K, Kraft CS, Mumma JM, Durso FT, Ferguson AN, Gipson CL, Walsh VL, Zimring C, DuBose J, Jacob JT; Centers for Disease Control and Prevention Epicenters Program, Division of Healthcare Quality Promotion.

Clin Infect Dis. 2018 Mar 5;66(6):945-949. doi: 10.1093/cid/cix956.

PMID:
29471475
20.

Human Factors Risk Analyses of a Doffing Protocol for Ebola-Level Personal Protective Equipment: Mapping Errors to Contamination.

Mumma JM, Durso FT, Ferguson AN, Gipson CL, Casanova L, Erukunuakpor K, Kraft CS, Walsh VL, Zimring C, DuBose J, Jacob JT; Centers for Disease Control and Prevention Epicenters Program, Division of Healthcare Quality Promotion.

Clin Infect Dis. 2018 Mar 5;66(6):950-958. doi: 10.1093/cid/cix957.

PMID:
29471368

Supplemental Content

Loading ...
Support Center